These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27627574)

  • 1. The Significance of Matrix Metalloproteinases in Oral Diseases.
    Maciejczyk M; Pietrzykowska A; Zalewska A; Knaś M; Daniszewska I
    Adv Clin Exp Med; 2016; 25(2):383-90. PubMed ID: 27627574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of matrix metalloproteinases in the oral environment.
    Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
    Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy.
    Yamachika S; Brayer J; Oxford GE; Peck AB; Humphreys-Beher MG
    Clin Exp Rheumatol; 2000; 18(2):233-40. PubMed ID: 10812497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
    De S; Fenton JE; Jones AS
    J Laryngol Otol; 2005 Jun; 119(6):436-42. PubMed ID: 15992468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions.
    Tjäderhane L; Larjava H; Sorsa T; Uitto VJ; Larmas M; Salo T
    J Dent Res; 1998 Aug; 77(8):1622-9. PubMed ID: 9719036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions.
    Siddhartha R; Garg M
    Toxicol Appl Pharmacol; 2021 Sep; 426():115593. PubMed ID: 34038713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjögren's syndrome patients: correlation with reduced structural integrity of acini and ducts.
    Goicovich E; Molina C; Pérez P; Aguilera S; Fernández J; Olea N; Alliende C; Leyton C; Romo R; Leyton L; González MJ
    Arthritis Rheum; 2003 Sep; 48(9):2573-84. PubMed ID: 13130477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
    Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
    Cells; 2020 May; 9(5):. PubMed ID: 32466129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome.
    Pérez P; Goicovich E; Alliende C; Aguilera S; Leyton C; Molina C; Pinto R; Romo R; Martinez B; González MJ
    Arthritis Rheum; 2000 Dec; 43(12):2807-17. PubMed ID: 11145040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
    Kim IS; Yang WS; Kim CH
    Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DENTINE CARIES: ACID-TOLERANT MICROORGANISMS AND ASPECTS ON COLLAGEN DEGRADATION.
    Lager AH
    Swed Dent J Suppl; 2014; (233):9-94. PubMed ID: 26688982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and periodontal diseases.
    Sapna G; Gokul S; Bagri-Manjrekar K
    Oral Dis; 2014 Sep; 20(6):538-50. PubMed ID: 23849049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of matrix metalloproteinases (MMPs) in human caries.
    Chaussain-Miller C; Fioretti F; Goldberg M; Menashi S
    J Dent Res; 2006 Jan; 85(1):22-32. PubMed ID: 16373676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases (MMPs) in oral diseases.
    Sorsa T; Tjäderhane L; Salo T
    Oral Dis; 2004 Nov; 10(6):311-8. PubMed ID: 15533204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
    Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
    Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.